Influenza Epidemics and Pandemics

Gabriele Neumann, University of Wisconsin‐Madison, Madison, Wisconsin, USA
Yoshihiro Kawaoka, University of Tokyo, Tokyo, Wisconsin, Japan

Published online: October 2010

DOI: 10.1002/9780470015902.a0002241.pub3

Influenza viruses can cause epidemics or pandemics (worldwide epidemics), during which acute febrile respiratory disease spreads rapidly among all age groups, accompanied by excess hospitalisation and death. Here, we describe the recorded influenza virus pandemics, including the most recent pandemic that was caused in 2009 by a novel virus of the H1N1 subtype. Influenza virus replication and adaptation to new hosts account for much of the evolutionary success of these viruses. We review the viral proteins that are known to affect host range and pathogenicity (i.e. the haemagglutinin protein HA, the neuraminidase protein NA, the polymerase protein PB2, the nonstructural protein NS1 and the PB1-F2 protein). We also discuss the clinical features of influenza virus infections, influenza virus immunology and influenza virus control, including antiviral treatment and vaccination.

Key Concepts:

  • Influenza A viruses cause annual epidemics that result from point mutations in the HA (and NA) proteins (antigenic drift).
  • At random intervals, influenza pandemics are caused by viruses that introduce HA proteins into the human population against which most humans lack immunity.
  • Influenza A viruses evolve through reassortment and point mutations.
  • Aquatic birds are the natural reservoir of influenza A viruses.
  • Influenza A viruses can be transmitted among species, despite host range restriction factors.
  • The HA protein is the major protective antigen and an important determinant of host range and pathogenicity.
  • The PB1, NS1 and PB1-F2 proteins are also important determinants of pathogenicity.
  • For seasonal and pandemic 2009 H1N1 influenza viruses, inactivated and live attenuated vaccines are available.
  • Two classes of antiviral compounds (ion channel inhibitors and neuraminidase inhibitors) exist: resistance to ion channel inhibitors is now widespread among circulating H1N1 and H3N2 influenza viruses; resistance to neuraminidase inhibitors has been reported for most seasonal H1N1 viruses, some pandemic 2009 H1N1 viruses and some highly pathogenic avian H5N1 influenza viruses.

Keywords: flu; pandemic; pandemic 2009 H1N1; genetic reassortment; antigenic drift; antigenic shift; interspecies transmission; avian influenza; bird flu; Spanish influenza

Figure 1. Genesis of pandemic 2009 H1N1 viruses. The NA and M genes were derived from an Eurasian avian-like swine virus (yellow). The remaining six genes were derived from triple resssortant swine viruses that possessed genes originating from classical H1N1 swine (red), North American avian (blue) and human H3N2 (green) viruses. Reproduced from Neumann et al. (2009), DOI: 10.1038/nature08157, with permission from Nature Publishing Group.
close
 References
    Basler CF, Reid AH, Dybing JK et al. (2001) From the cover: Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proceedings of the National Academy of Sciences of the USA 98: 2746–2751.
    Chen W, Calvo PA, Malide D et al. (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nature Medicine 7: 1306–1312.
    Cheung CY, Poon LL, Lau AS et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360: 1831–1837.
    Claas EC, de Jong JC, Van Beek R, Rimmelzwaan GF and Osterhaus AD (1998a) Human influenza virus A/HongKong/156/97 (H5N1) infection. Vaccine 16: 977–978.
    Claas EC, Osterhaus AD, Van Beek R et al. (1998b) Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351: 472–477.
    Conenello GM, Zamarin D and Perrone LA (2007) A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathogen 3: 1414–1421.
    book Cox NJ, Neumann G, Donis RO and Kawaoka Y (2005) "Orthomyxoviruses: influenza". In: Collier L, Balows A and Sussman M (eds) Topley & Wilson's Microbiology and Microbial Infections, pp. 634–698. London: Arnold.
    Dawood FS, Jain S and Finelli L (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New England Journal of Medicine 360: 2605–2615.
    Fouchier RA, Schneeberger PM, Rozendaal FW et al. (2004) Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proceedings of the National Academy of Sciences of the USA 101: 1356–1361.
    Garcia-Sastre A (2001) Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279: 375–384.
    Garcia-Sastre A, Durbin RK, Zheng H et al. (1998a) The role of interferon in influenza virus tissue tropism. Journal of Virology 72: 8550–8558.
    Garcia-Sastre A, Egorov A, Matassov D et al. (1998b) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252: 324–330.
    Garten RJ, Davis CT and Russell CA (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197–201.
    Geiss GK, Salvatore M, Tumpey TM et al. (2002) Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proceedings of the National Academy of Sciences of the USA 99: 10736–10741.
    Hai R, Schmolke M, Varga ZT et al. (2010) PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. Journal of Virology 84: 4442–4450.
    Hatta M, Gao P, Halfmann P and Kawaoka Y (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840–1842.
    Horimoto T and Kawaoka Y (2005) Influenza: lessons from past pandemics, warnings from current incidents. Nature Reviews. Microbiology 3: 591–600.
    Itoh Y, Shinya K, Kiso M et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021–1025.
    Kash JC, Tumpey PM and Proll SC (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578–581.
    Kobasa D, Jones SM, Shinya K et al. (2007a) Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445: 319–323.
    Kobasa D, Takada A, Shinya K et al. (2004) Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431: 703–707.
    Kobasa D, Takada A, Shinya K et al. (2007b) Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431: 703–707.
    Krug RM, Yuan W, Noah DL and Latham AG (2003) Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309: 181–189.
    book Lamb RA and Krug RM (2001) "Orthomyxoviridae: the viruses and their replication". In: Knipe DM, Howley PM, Griffin DE et al. (eds) Fields Virology, pp. 1487–1532. Philadelphia: Lippincott Williams & Wilkins.
    Maines TR, Jayaraman A, Belser JA et al. (2009) Transmission and pathogenicity of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325: 484–487.
    Matrosovich MN, Matrosovich TY, Gray T, Roberts NA and Klenk HD (2004) Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proceedings of the National Academy of Sciences of the USA 101: 4620–4624.
    Mazur I, Anhlan D, Mitzner D et al. (2008) The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cellular Microbiology 10: 1140–1152.
    McAuley JL, Hornung F, Boyd KL et al. (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host & Microbe 2: 240–249.
    Mehle A and Doudna JA (2009) Adaptive strategies of the influenza virus polymerase for replication in humans. Proceedings of the National Academy of Sciences of the USA 106: 21312–21316.
    Munster VJ, de Wit E, van den Brand JMA et al. (2009) Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325: 481–483.
    Neumann G, Noda T and Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931–999.
    Peiris JS, Yu WC, Leung CW et al. (2004) Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363: 617–619.
    Reid AH, Fanning TG, Janczewski TA, Lourens RM and Taubenberger JK (2004) Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. Journal of Virology 78: 12462–12470.
    Reid AH, Fanning TG, Hultin JV and Taubenberger JK (1999) Origin and evolution of the 1918 “Spanish” influenza virus hemagglutinin gene. Proceedings of the National Academy of Sciences of the USA 96: 1651–1656.
    Reid AH, Fanning TG, Janczewski TA, McCall S and Taubenberger JK (2002) Characterization of the 1918 “Spanish” influenza virus matrix gene segment. Journal of Virology 76: 10717–10723.
    Reid AH, Fanning TG, Janczewski TA and Taubenberger JK (2000) Characterization of the 1918 “Spanish” influenza virus neuraminidase gene. Proceedings of the National Academy of Sciences of the USA 97: 6785–6790.
    Seo SH, Hoffmann E and Webster RG (2002) Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nature Medicine 8: 950–954.
    Shinya K, Ebina M, Yamada S et al. (2006) Avian flu: influenza virus receptors in the human airway. Nature 440: 435–436.
    Smith GJ, Vijaykrishna D, Bahl J et al. (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459: 1122–1125.
    Subbarao K, Klimov A, Katz J et al. (1998) Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279: 393–396.
    Taubenberger JK, Reid AH, Lourens RM et al. (2005) Characterization of the 1918 influenza virus polymerase genes. Nature 437: 889–893.
    Tumpey TM, Basler CF, Aguilar PV et al. (2005) Characterization of the reconstituted 1918 Spanish pandemic virus. Science 310: 77–80.
    Tumpey TM, Garcia-Sastre A, Mikulasova A et al. (2002) Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proceedings of the National Academy of Sciences of the USA 99: 13849–13854.
    Tumpey TM, Garcia-Sastre A, Taubenberger JK et al. (2004) Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proceedings of the National Academy of Sciences of the USA 101: 3166–3171.
    Van Hoeven N, Pappas C, Belser CA et al. (2009) Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proceedings of the National Academy of Sciences of the USA 106: 3366–3371.
    Van Riel D, Munster VJ, de Wit E et al. (2006) H5N1 virus attachment of lower respiratory tract. Science 312: 399.
    Watanabe T, Watanabe S, Shinya K et al. (2009) Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. Proceedings of the National Academy of Sciences of the USA 106: 588–592.
    book Wright PF, Neumann G and Kawaoka Y (2007) "Orthomyxoviruses". In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Marting MA, Roizman B and Straus SE (eds) Fields Virology, pp. 1727–1740. Philadelphia: Wolters Kluwer; Lippincott Williams & Wilkins.
 Further Reading
    Minor PD (2010) Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for vaccine production. Clinical Infectious Diseases 50: 560–565.
    Munster VJ and Fouchier RA (2009) Avian influenza virus: of virus and bird ecology. Vaccine 27: 6340–6344.
    Schmolke M and Garcia-Sastre A (2010) Evasion of innate and adaptive immune responses by influenza A viruses. Cellular Microbiology 12: 873–880.
    Taubenberger JK and Kash JC (2010) Influenza virus evolution, host adaptation, and pandemic formation. Cell Host & Microbe 7: 440–451.
    Wang TT and Palese P (2009) Unraveling the mystery of swine influenza virus. Cell 137: 983–985.
    Webster RG, Hulse-Post DJ, Sturm-Ramirez KM et al. (2007) Changing epidemiology and ecology of highly pathogenic avian H5N1 influenza viruses. Avian Diseases 51(1 Suppl.): 269–272.

Related Sub-Topics:

Virus Diseases | Viruses Infecting Humans | Viruses Infecting Animals
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

Article Title: Influenza Epidemics and Pandemics
 
How to Cite close
Neumann, Gabriele, and Kawaoka, Yoshihiro(Oct 2010) Influenza Epidemics and Pandemics. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0002241.pub3]